CrestPoint Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.08M | Sell |
12,800
-2,700
| -17% | -$228K | 0.6% | 57 |
|
|
2017
Q3 | $1.33M | Sell |
15,500
-700
| -4% | -$59.9K | 0.59% | 55 |
|
|
2017
Q2 | $1.33M | Buy |
16,200
+4,000
| +33% | +$329K | 0.63% | 55 |
|
|
2017
Q1 | $1.03M | Buy |
12,200
+9,300
| +321% | +$782K | 0.49% | 68 |
|
|
2016
Q4 | $213K | Hold |
2,900
| – | – | 0.11% | 210 |
|
|
2016
Q3 | $233K | Buy |
2,900
+20
| +0.7% | +$1.61K | 0.12% | 202 |
|
|
2016
Q2 | $227K | Hold |
2,880
| – | – | 0.12% | 192 |
|
|
2016
Q1 | $207K | Hold |
2,880
| – | – | 0.11% | 201 |
|
|
2015
Q4 | $243K | Hold |
2,880
| – | – | 0.14% | 165 |
|
|
2015
Q3 | $241K | Hold |
2,880
| – | – | 0.14% | 170 |
|
|
2015
Q2 | $240K | Hold |
2,880
| – | – | 0.13% | 202 |
|
|
2015
Q1 | $209K | Buy |
+2,880
| New | +$209K | 0.11% | 213 |
|
|
2014
Q3 | – | Sell |
-4,480
| Closed | -$279K | – | 214 |
|
|
2014
Q2 | $279K | Sell |
4,480
-200
| -4% | -$12.5K | 0.16% | 176 |
|
|
2014
Q1 | $275K | Sell |
4,680
-8,400
| -64% | -$494K | 0.17% | 177 |
|
|
2013
Q4 | $667K | Buy |
+13,080
| New | +$667K | 0.44% | 86 |
|